888.298.HOPE

Posts Tagged ‘MedPage Today’

By On August 30th, 2013

Depression in Men Manifests Differently

The clinical picture of a woman who is depressed is different from that of a man who is experiencing depression.  Men with depression may show symptoms of anger or aggression, signs of substance abuse or risky behavior.  A recent study found that the tools used to screen for depression focus on symptoms typically reported by…

Read

By On August 8th, 2013

It Is Important to Identify Mental Distress Quickly After Trauma

In the aftermath of disaster, emergency mental health responses should focus on identification of individuals in need, triage, and appropriate interventions, according to a systematic literature review published in the Aug. 7 issue of Journal of the American Medical Association. The review examined 222 articles discussing mental health concerns after large-scale disasters such as the…

Read

By On August 5th, 2013

Autism Can Be Identified By Chemical Changes in Brain

Researchers may have a new way to diagnose autism spectrum disorders (ASD), as they have discovered children with ASD between the ages of 3 and 10 undergo chemical changes in their brain distinguishable from children with other developmental disorders. Specifically, MedPage Today reports concentrations of N-acetylaspartate, which plays important roles in several functions, rises over…

Read

By On July 11th, 2013

Schizophrenia Linked To Mutation In Serotonin Receptor

New research published in JAMA Psychiatry suggests doctors may have found a mutation in the gene for a serotonin receptor that plays a functional role in schizophrenia, including how patients respond to treatment. As reported by Michael Smith, correspondent for MedPage Today, the mutation in the gene for serotonin receptor 2a is a single nucleotide…

Read

By On May 20th, 2013

Ketamine Remains A Promising Treatment Option

Ketamine, an anesthetic agent, has been the jumping off point for a number of studies in the past few months. Researchers have theorized that it can be helpful in a number of psychiatric disorders, including obsessive compulsive disorder, depression and even some forms of autism. John Gever, of MedPage Today, reports that the drug is…

Read

By On May 14th, 2013

Peppers Could Reduce Parkinson’s Risk

Several studies have examined the fact that smokers are less likely to develop Parkinson’s disease and now researchers believe that it could be due to “a neuroprotective effect of nicotine.” Trading for cancer risks and lung disease isn’t a great way to avoid Parkinson’s, however, so experts recently examined the effect of consuming vegetables in…

Read

By On May 7th, 2013

Promising Alzheimer’s Treatment Fails In Trials

Intravenous immunoglobulin, or IVIG, had performed admirably in research being performed by doctors searching for an effective treatment of Alzheimer’s disease. In a phase II trial, IVIG appeared to show an ability to effectively stop the disease’s progression over a three year period. However, in the expanded phase III trial, patients showed no significant improvement…

Read

By On May 2nd, 2013

Regardless Of Age, Heart Health And Cognitive Function Linked

It has been known for some time that poor cardiovascular health can contribute, or be a predictor, to diminishing cognitive function in middle aged to elderly adults. But recent research suggests that this holds true for all individuals, regardless of age. Crystal Phend, of MedPage Today, reports that “cognitive function dropped by 1.5 points on…

Read

By On April 30th, 2013

Autism And Lyme Disease No Longer Believed To Be Linked

In 2008, a theory was proposed that individuals with autism spectrum disorder had about a 1 in 5 chance of also having Lyme disease. A recent study appearing in the latest issue of the Journal of the American Medical Association refutes that claim definitively finding no link between autism and Lyme disease. As Charlene Laino…

Read

By On April 29th, 2013

FDA Warns About Seizure Medication

The FDA has issued a warning to consumers concerning the anti-seizure drug ezogabine (Potiga). As reported by MedPage Today, the drug can cause “blue skin discoloration” and “pigment changes in retinas”. A loss of vision and eye disease are possible if the drug is continued to be used after initial symptoms arise, but doctors urge patients…

Read
Logo Logo

©2021 Brookhaven Hospital. All Rights Reserved.